期刊文献+

磷霉素对肠球菌的接种效应 被引量:1

The inoculum effect of fosfomycin in tests with Enterococcus
原文传递
导出
摘要 目的 与青霉素、利福平、万古霉素、替考拉宁等4种常用抗菌药物对比研究,分析磷霉素对肠球菌的接种效应.方法 选择2010年1月至2012年1月自中国医科大学附属第一医院住院患者分离的91株肠球菌,均为不重复菌株,包括粪肠球菌44株,屎肠球菌47株.采用琼脂稀释法测定磷霉素、青霉素、利福平、万古霉素、替考拉宁5种抗菌药物对91株肠球菌在低接种浓度[1×10^5菌落形成单位(cfu)/mL]和高接种浓度(1×10^7 cfu/mL)下的最低抑菌浓度(MIC).结果 对于所有受试菌株,磷霉素在高接种浓度、低接种浓度下的MIC值均波动在16~64 μg/mL之间.受试菌株,不管是粪肠球菌,还是屎肠球菌,均对磷霉素的敏感率最高(100.0%),耐药率最低(0).磷霉素、青霉素、利福平、万古霉素、替考拉宁5种抗菌药物随着菌株接种浓度的增加,其菌株MIC值均升高不足8倍,即均不存在接种效应.结论 对于肠球菌引起的感染,由于磷霉素体外药物敏感试验显示其敏感性高,且不存在接种效应,因此可用于临床治疗. Objective To investigate the inoculum effect of fosfomycin on enterococci,in comparison with penicillin,rifampin,vancomycin and teicoplanin.Methods A total of 91 strains of enterococci were obtained from the patients hospitalized in The First Affiliated Hospital of China Medical University from January 2010 to January 2012.There was no repeated strain.The 91 strains consisted of 44 Enterococcus faecalis and 47 Enterococcus faecium strains.Agar dilution method was used to measure the minimum inhibitory concentrations (MIC) of the five antibiotics against the 91 enterococci strains under standard low inoculation concentration (1 × 10^5 colony-forming units [cfu]/mL) and high inoculation concentration (1 × 10^7 cfu/mL).Results For all tested strains,MIC of fosfomycin fluctuated between 16-64 tμg/mL in high and low inoculated concentrations.Among the tested strains,both Enterococcus faecalis and Enterococcus faecium had the highest drug-sensitive rate (100.0%) and the lowest drugresistance rate (0) to fosfomycin.With the increase of the inoculation concentration,MIC of the five antibiotics increased less than 8 times,which indicated that there was no inoculation effect.Conclusion Fosfomycin shows high drug-sensitivity against enterococci without inoculum effect in vitro,and it is recommended for the treatment of enterococci-infected patients.
出处 《中华传染病杂志》 CAS CSCD 北大核心 2015年第2期87-90,共4页 Chinese Journal of Infectious Diseases
关键词 肠球菌 接种效应 磷霉素 Enterococcus Inoculum effect Fosfomycin
  • 相关文献

参考文献10

  • 1Paterson DL, Ko WC, Von Gottberg A, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory [J]. J Clin Microbiol, 2001,39(6) :2206-2212. 被引量:1
  • 2吴娜,褚云卓,田素飞,陈佰义.抗菌药物对产超广谱β内酰胺酶大肠埃希菌和肺炎克雷伯菌接种效应的研究[J].中国感染与化疗杂志,2011,11(1):31-35. 被引量:13
  • 3汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 4Thomson KS, Moland ES. Cefepime, piperacillin-tazobactam, and the inoculums effect in tests with extended-spectrum beta- laetamase-producing Enterobacteriaceae [ J ]. Antimicroh Agents Chemother, 2001,45(12) :3548-3554. 被引量:1
  • 5俞树荣主编..微生物学和微生物学检验 第2版[M].北京:人民卫生出版社,1988:489.
  • 6文细毛,任南,吴安华,徐秀华.全国医院感染监控网医院感染病原菌分布及变化趋势[J].中华医院感染学杂志,2011,21(2):350-355. 被引量:265
  • 7Moellering RC Jr. Emergence o{ Enterococcus as a significant pathogen [J]. Clin Infect Dis, 1992,14(6):1173-1176. 被引量:1
  • 8Barie PS. Antibiotic-resistant gram-positive cocci: implications for surgical practice [J]. WorLd J Surg, 1998,22(2) :118-126. 被引量:1
  • 9Linden PK, Miller CB. Vancomycin-resistant enterococci: the clinical effect of a common nosoeomial pathogen [J]. Diagn Microbiol Infect Dis, 1999,33(2) : 113-120. 被引量:1
  • 10Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-laetamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam [J]. Clin Microbiol Infect, 2008,14 Suppl 1 : 181-184. 被引量:1

二级参考文献38

  • 1张群,席淑华,谢少飞,薛静洁,彭洁洁.普通外科围手术期抗菌药物合理使用的干预对照研究[J].中国感染控制杂志,2007,6(4):247-249. 被引量:33
  • 2Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009. 被引量:1
  • 3Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19). 被引量:1
  • 4Yang QW, Wang H, Sun HL, et al. Phenotypic and geno typic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillance studies in China[J]. Antimicrob Agents Chemother,2010, 54(1): 573-577. 被引量:1
  • 5Wang H, Guo P, Sun HL et al. Molecular epidemiology of clinical isolates of carbapenem resistant Acinetobacter spp from chinese hospitals[J]. Antimicrob Agents Chemother, 2007, 51(11): 4022-4028. 被引量:1
  • 6Perez F, Hujer AM, Hujer KM et al. Global challenge of multidrug resistantAcinetobacterbaumannii[J]. Antimicrob Agents Chemother,2007,51(10) : 3471-3484. 被引量:1
  • 7Boucher HW, Talbot G, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the IDSA[J]. Clin Infent Dis, 2009, 48(1):1-12. 被引量:1
  • 8Li J, Nation RL, Milne RW, et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria [J]. Intl J Antimicrob Agents, 2005, 25(1).-11 25. 被引量:1
  • 9Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae : a report of 2 cases and a brief review of the literature[J]. Clin Infent Dis, 2009,49(2):271-274. 被引量:1
  • 10Pachon Ibanez ME, Jimenez Mejias ME, Pichardo C, et al Activity of tigeeyeline (GAR 936) against Acinetobacter bau mannii strains, including those resistant to imipenem[J] Antimicrob Agents Chemother, 2004,48 ( 11 ):4479-4481. 被引量:1

共引文献665

同被引文献19

  • 1Gedik H,Simsek F,Kantürk A,et al.Vancomycin-resistant Enterococci colonization in patients with hematological malignancies:screening and its cost-effectiveness[J].Afr Health Sci,2014,14(4):899-905. 被引量:1
  • 2Singh LK,Maheshwari DK,Shukla S.Antibacterial effect of butyryl alkannin from Arnebia euchroma against vancomycinresistant pathogens of Enterococcus faecalis causing urinary tract infections[J].Nat Prod Res,2015,29(24):2299-2301. 被引量:1
  • 3Lyu SY,Liu YC,Chang CY,et al.Multiple complexes of long aliphatic N-acyltransferases lead to synthesis of 2,6-diacylated/2-acyl-substituted glycopeptide antibiotics,effectively killing vancomycin-resistant Enterococcus[J].J Am Chem Soc,2014,136(31):10989-10995. 被引量:1
  • 4Jovanovic M,Milosevic B,Tosic T,et al.Molecular typing,pathogenicity factor genes and antimicrobial susceptibility of vancomycin resistant Enterococciin Belgrade,Serbia[J].Acta Microbiol Immunol Hung,2015,62(2):147-160. 被引量:1
  • 5Correa AA,Pignatari AC,da Silveira M,et al.Small hospitals matter:insights from the emergence and spread of vancomycin-resistant Enterococci in 2public hospitals in inner Brazil[J].Diagn Microbiol Infect Dis,2015,82(3):227-233. 被引量:1
  • 6Yarlagadda V,Sarkar P,Manjunath GB,et al.Lipophilic vancomycin aglycon dimer with high activity against vancomycinresistant bacteria[J].Bioorg Med Chem Lett,2015,25(23):5477-5480. 被引量:1
  • 7Masila VM,Midiwo JO,Zhang J,et al.Anti-vancomycin-resistant Enterococcus faeciumand E.faecalis activities of(-)-gossypol and derivatives from Thespesia garckeana[J].Nat Prod Commun,2015,10(4):613-616. 被引量:1
  • 8Singh K,Kumar S,Shekhar S,et al.Synthesis and biological evaluation of novel peptide BF2as an antibacterial agent against clinical isolates of vancomycin-resistant Enterococci[J].J Med Chem,2014,57(21):8880-8885. 被引量:1
  • 9Munita JM,Murray BE,Arias CA.Daptomycin for the treatment of bacteraemia due to vancomycin-resistant Enterococci[J].Int J Antimicrob Agents,2014,44(5):387-395. 被引量:1
  • 10Hall Snyder A,Werth BJ,Barber KE,et al.Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant Enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model[J].J Antimicrob Chemother,2014,69(8):2148-2154. 被引量:1

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部